Super CC Plus Cream
- Manufacturer
- Baja Fur, S.A. de C.V.
- Effective date
- 2021-09-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:34:38
Label at a glance#
ProductSuper CC Plus Cream SPF 30
Active ingredientTITANIUM DIOXIDE, ZINC OXIDE
Label structure1 sections
Label contents#
Full prescribing information#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71413-173-02 | 2023-01-30 | C162847 | 48780-1 | f386c649-b479-0266-e053-dadaa90a7c1a | Super CC Cream-6234, 6235, 71413-173 |
Products#
Every source-derived product name is available through these pages.
- Super CC Plus Cream SPF 30
- Titanium Dioxide, Zinc Oxide
- HYDROXYCAPRYLIC ACID
- SHEA BUTTER
- TETRAHEXYLDECYL ASCORBATE
- .ALPHA.-TOCOPHEROL ACETATE
- CAPRYLYL GLYCOL
- EDETATE DISODIUM
- DISTEARDIMONIUM HECTORITE
- ETHYLHEXYLGLYCERIN
- GLYCERYL STEARATE SE
- HEXYLENE GLYCOL
- LAURETH-12
- MICA
- PEG/PPG-18/18 DIMETHICONE
- POLYSORBATE 60
- PROPYLENE CARBONATE
- SODIUM HYDROXIDE
- TRIETHOXYCAPRYLYLSILANE
- XANTHAN GUM
- PHENOXYETHANOL
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
- TITANIUM DIOXIDE
- ZINC OXIDE
- ZINC CATION
- WATER
- BUTYLENE GLYCOL
- DIMETHICONE
- NEOPENTYL GLYCOL DIHEPTANOATE
- CETOSTEARYL ALCOHOL
- PEG-10 DIMETHICONE (600 CST)
- SODIUM CHLORIDE
- CALCIUM ALUMINUM BOROSILICATE
- GLYCERIN
- TEPRENONE
- HYDROXYCAPRIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 71413-173 | 71413-173-01, 71413-173-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cd2bc9db-85a7-774e-e053-2995a90a368a | cd2bc9db-85a6-774e-e053-2995a90a368a | 2021-09-29 | cd2bc9db-85a7-774e-e053-2995a90a368a cd2bc9db-85a6-774e-e053-2995a90a368a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
